Venmax Drugs and Pharmaceuticals Limited announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced total revenue was INR 0.984 million compared to INR 1.188 million a year ago. Net loss was INR 0.858 million compared to net income of INR 0.246 million a year ago. Basic loss per share from continuing operations was INR 0.16 compared to basic earnings per share from continuing operations of INR 0.05 a year ago. For the half year, total revenue was INR 1.679 million compared to INR 2.046 million a year ago. Net loss was INR 1.513 million compared to INR 0.155 million a year ago. Basic loss per share from continuing operations was INR 0.29 compared to INR 0.03 a year ago.